CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. Submitted by CEHS on Sun, 2014-04-27 10:58 Taghizadeh, R. et al. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. PLoS One 5, e15183 (2010). Log in to post commentsPubMedDOI